申请人:Sabre Therapeutics LLC
公开号:EP3878848A1
公开(公告)日:2021-09-15
Described herein are compounds that are autotaxin inhibitors, methods of making such compounds, pharmaceutical compositions and medicaments comprising such compounds, and methods of using such compounds in the treatment of conditions, diseases, or disorders associated with autotaxin activity.
本文描述了作为自旋松弛素抑制剂的化合物、制造此类化合物的方法、包含此类化合物的药物组合物和药物,以及使用此类化合物治疗与自旋松弛素活性相关的病症、疾病或失调的方法。